"Beneficial Anti-Diabetic and Anti-Inflammatory Effects of a New Class of Lipids"

Made possible by the I.G. Bromberg Memorial Visiting Professorship.

To welcome our distinguished guest speaker, this will be an in-person only event. Group viewing sites will be available for those who are on clinical service.

Speaker:

Barbara B. Kahn, M.D.
George R. Minot Endowed Chair and Professor of Medicine
Harvard Medical School
Vice Chair for Research Strategy, Department of Medicine
Beth Israel Deaconess Medical Center
Institute Member, the Broad Institute of MIT and Harvard

About Barbara Kahn:

Dr. Kahn received her bachelor's degree and her medical degree from Stanford University. She also holds a master's degree in health sciences from the University of California at Berkeley. After completing internal medicine training and a general medicine fellowship at the UC Davis Medical Center, she began her career in molecular research at the National Institutes of Health, where she also completed a clinical endocrine fellowship.

Her research focuses on insulin resistance and type 2 diabetes. Her lab has identified signaling pathways involved in insulin sensitivity, weight maintenance, and regulation of hunger. She has also been involved in research on the GLUT 4 transporter and its role in the regulation of glucose tolerance.